Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Leukaemia Section Short Communication t(5;7)(q33;q11) Jean-Loup Huret Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France Published in Atlas Database: August 1998 Online updated version: http://AtlasGeneticsOncology.org/Anomalies/t057ID1062.html DOI: 10.4267/2042/37462 This work is licensed under a Creative Commons Attribution-Non-commercial-No Derivative Works 2.0 France Licence. © 1998 Atlas of Genetics and Cytogenetics in Oncology and Haematology Clinics and pathology Results of the chromosomal anomaly Disease Only one case available to date: a 54 yr old man with chronic myelomonocytic leukaemia. Prognosis Yet unknown. Hybrid gene Genes involved and Proteins Fusion protein Description 5' HIP1- 3' PDGFRb; breakpoint in PDGFRb similar to what is found in the t(5;12)(q33;p12). Description 180 kDa; contained nearly all of the HIP1 coding sequence, including the leucine zipper and talin homology domains, fused in frame to the transmembrane and tyrosine kinase domain of the PDGFb; the reciprocal PDGFb-HIP1 transcript is not expressed. Oncogenesis Constitutive activation of PDGFb (by tyrosine autophosphorylation). PDGFRB Location: 5q33 Protein Contains from N-term to C-term: a ligand binding domain, a transmembrane domain, and a Tyrosine kinase domain; PDGFRB is the receptor for PDGFB (platelet-derived growth factor-b); membrane protein; belongs to the immunoglobulin superfamily. HIP1 References Location: 7q11 Protein Contains a leucine zipper and, in C-term, a region with homology to a protein of the cytoskeleton; membrane associated protein. Ross TS, Bernard OA, Berger R, Gilliland DG. Fusion of Huntingtin Interacting Protein to Platelet-Derived Growth Factor beta Receptor (PDGF betaR) in Chronic Myelomonocytic Leukemia with t(5;7)(q33;q11.2). Blood, Vol 91 No. 12 (June 15), 1998: 4419-26. This article should be referenced as such: Huret JL. t(5;7)(q33;q11). Atlas Genet Cytogenet Oncol Haematol.1998;2(4):142. Atlas Genet Cytogenet Oncol Haematol. 1998;2(4) 142